Accuracy of a Single, Heparin-Calibrated Anti-Xa Assay for the Measurement of Rivaroxaban, Apixaban, and Edoxaban Drug Concentrations: A Prospective Cross-Sectional Study

BACKGROUND: Applying a single anti-Xa assay, calibrated to unfractionated heparin to measure rivaroxaban, apixaban, and edoxaban would simplify laboratory procedures and save healthcare costs. AIM: We hypothesized that a heparin-calibrated anti-Xa assay would accurately measure rivaroxaban, apixaban...

Descripción completa

Detalles Bibliográficos
Autores principales: Meihandoest, Tamana, Studt, Jan-Dirk, Mendez, Adriana, Alberio, Lorenzo, Fontana, Pierre, Wuillemin, Walter A., Schmidt, Adrian, Graf, Lukas, Gerber, Bernhard, Amstutz, Ursula, Bovet, Cedric, Sauter, Thomas C., Asmis, Lars M., Nagler, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969025/
https://www.ncbi.nlm.nih.gov/pubmed/35369293
http://dx.doi.org/10.3389/fcvm.2022.817826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969025/
https://www.ncbi.nlm.nih.gov/pubmed/35369293
http://dx.doi.org/10.3389/fcvm.2022.817826

Ejemplares similares